Dr. David Krause is Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than 25 years of experience in pharmaceutical research and development and medical affairs. At Genomind, he is responsible for clinical research and serves as liaison to the community of Genomind’s patients, customers and subject matter experts. Prior to joining Genomind, Dr. Krause was the head of several global therapeutic areas at SmithKline Beecham and GlaxoSmithKline. He was also Chief Medical Officer at Vicuron Pharmaceuticals, which was acquired by Pfizer, Inc. in 2006.

Dr. Krause is a Fellow of the American College of Physicians, and author of more than 40 scientific publications and abstracts, and has served as a consultant to the Department of Defense.

Education
Dr. Krause is a graduate of the Pennsylvania State University, where he was named a Centennial Fellow by the College of Liberal Arts, and received his MD degree from Temple University.